Provided by Tiger Fintech (Singapore) Pte. Ltd.

Immutep Limited

1.54
+0.09006.21%
Post-market: 1.46-0.0780-5.06%17:30 EDT
Volume:12.96K
Turnover:19.58K
Market Cap:224.16M
PE:-7.56
High:1.55
Open:1.47
Low:1.46
Close:1.45
Loading ...

Immutep Reports Promising Phase II Sarcoma Trial Results

TIPRANKS
·
15 Nov 2024

Immutep price target raised to $7 from $6 at Baird

TIPRANKS
·
15 Nov 2024

Sector Update: Health Care Stocks Lower Thursday Afternoon

MT Newswires Live
·
15 Nov 2024

Immutep Shares Rally Following Positive Phase 1 Trial Data of Efti Combination Therapy in Non-Small Cell Lung Cancer

MT Newswires Live
·
14 Nov 2024

Immutep ADRs Climb on Positive Efti Trial Results

Dow Jones
·
14 Nov 2024

Immutep announces data from INSIGHT-003 trial

TIPRANKS
·
14 Nov 2024

Immutep’s Efti Shows Excellent Survival Data from INSIGHT-003 Trial in Non-Small Cell Lung Cancer

GlobeNewswire
·
14 Nov 2024

Positive Data from Phase II Trial in Soft Tissue Sarcoma Presented at CTOS 2024 Annual Meeting

GlobeNewswire
·
14 Nov 2024

Immutep Limited's (ASX:IMM) institutional shareholders had a great week as one-year returns increased after a 11% gain last week

Simply Wall St.
·
12 Nov 2024

Immutep (ASX:IMM) shareholders have endured a 51% loss from investing in the stock three years ago

Simply Wall St.
·
07 Nov 2024

Immutep’s Growth and Advancements Boost Market Visibility

TIPRANKS
·
30 Oct 2024

Immutep Quarterly Activities Report Q1 FY25

GlobeNewswire
·
29 Oct 2024

Immutep to Present New Phase IIb Data in PD-L1 Negative (CPS <1) Head and Neck Cancer at ESMO Immuno-Oncology 2024

GlobeNewswire
·
28 Oct 2024

Immutep Faces Cybersecurity Threats: Potential Delays and Liabilities in Product Development

TIPRANKS
·
23 Oct 2024

Immutep Limited Announces 2024 AGM Details

TIPRANKS
·
22 Oct 2024

Immutep Limited Announces 2024 Financial Performance

TIPRANKS
·
22 Oct 2024